TIL Therapy Uses the Body’s Own Cells to Attack Cancer Cells in …
1 天前 · In February 2024, Amtagvi (lifileucel) was the first FDA-approved TIL therapy to treat patients with advanced melanoma whose disease progressed on or after anti-PD-1/PD-L1 therapy and targeted therapy. With TIL therapy, T cells are extracted from a patient’s tumor, grown in a lab and then reinfused back into the patient to attack cancer cells.
CURE - Oncology & Cancer News for Patients & Caregivers
Oncology Approvals, Psychological Outcomes for Survivors and an Ovarian Cancer Vaccine. Cannabis Talks During Cancer, Cardiometabolic Comorbidities and Current Research. FDA Approvals from February 2024. Pancreatic Cancer Approval, Expert Discussion on Cancer Vaccine Development. Guidelines for Childhood Neuroblastoma, FDA Decisions and More.
Managing Trodelvy’s Side Effects Through Dose Adjustment
2 天之前 · Common side effects include neutropenia, anemia, and fatigue, but are generally manageable. Dose adjustments can reduce side effects without affecting Trodelvy's efficacy, especially in older or heavily pre-treated patients. Personalized dosing strategies are crucial for optimizing treatment outcomes with Trodelvy. SHOW MORE. An expert told ...
FDA Approves CAR-T Cell Therapy for Relapsed or Refractory B …
6 天之前 · The Food and Drug Administration (FDA) approved the CAR-T cell therapy Aucatzyl (obecabtagene autoleucel) for the treatment of adults with relapsed or refractory B-cell precursor acute lymphoblastic leukemia (B-cell ALL), according to an alert from the agency. The approval was based on findings from the FELIX trial, which assessed Aucatzyl in ...
Rest and Recuperation After a Cancer Diagnosis and Treatment
6 天之前 · Rest and recuperation are essential after cancer treatment, even when remission is achieved, to prevent health issues. The COVID-19 pandemic added stress and responsibilities, complicating recovery for cancer survivors. Personal experiences emphasize the importance of slowing down and seeking support to aid recovery and prevent complications.
Early Data Show Benefits With Ameluz-Photodynamic Therapy in …
2024年11月4日 · Patients with superficial basal cell carcinoma may benefit from receiving Ameluz-photodynamic therapy, early data from a phase 3 trial has shown. Preliminary results from a phase 3 trial demonstrate that photodynamic therapy with Ameluz (aminolevulinic acid HCl) led to complete clearance of a target lesion in patients with superficial basal ...
All News - Curetoday
Yankees Gift World Series Tickets to Pediatric Patient, “The Warriors” Star Dies and More. Alex Biese. November 1st 2024. From World Series tickets given to a pediatric patient with cancer to the death of David Harris, known as Cochise in “The Warriors,” at the age of 75, here is this week’s cancer news.
6 FDA Cancer Approvals from August 2024 - Curetoday
2024年8月21日 · CURE® took a look at six recent FDA approvals in the solid and blood cancer space. During the summer of 2024, the Food and Drug Administration (FDA) approved a handful of cancer treatments for patients with both solid and blood cancers. In August, the agency approved six more treatments, ranging from non-small cell lung cancer (NSCLC) to ...
Keytruda Has Received Nearly 40 FDA Approvals. How Does It Work?
2024年1月25日 · An expert explains how immunotherapy works. The Food and Drug Administration (FDA) recently approved Keytruda (pembrolizumab) plus chemoradiotherapy (CRT) for the treatment of patients with stages 3 to 4A cervical cancer. The first approval of an anti-programmed death receptor-1 (PD-1) therapy in combination with chemoradiotherapy for this ...
Myeloma | Oncology & Cancer News | CURE - Curetoday
2024年11月7日 · In patients with relapsed or refractory multiple myeloma, KRd56 and KRd27 showed similar effectiveness and safety, but other treatment options may be better. Carvykti Effective for R/R Multiple Myeloma in Real-World Setting. By Alex Biese. November 5th 2024. Jenna Fischer Shares Breast Cancer Details, Los Angeles Dodgers Broadcaster in ...